E65-21621-62345
4 vaccinations
1 coded response
13 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 487 / MI
- Registered
- 2022-12-29
- Relationship
- Child or adolescent in my care
- Guardian
- 88W-19561-11347
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-15
Dose 1 — Pfizer-BioNTech
-
2021-06-05
Dose 2 — Pfizer-BioNTech
-
2022-01-19
Dose 3 — Pfizer-BioNTech
-
2022-12-28
Dose 4 — Moderna
-
2022-12-29
Registered in v-safe
-
2022-12-29
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-12-30
- 2022-12-31
- 2023-01-01
- 2023-01-02
- 2023-01-04
- 2023-01-14
- 2023-01-19
- 2023-01-25
-
2023-02-01
Survey response — day 35, dose 4, dependentMedDRA: Nasal congestion — Feeling: GoodMedDRA releases: 2024-11
- 2023-02-08
- 2023-03-31
- 2023-06-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-15 | Pfizer-BioNTech | No |
| 2 | 2021-06-05 | Pfizer-BioNTech | No |
| 3 | 2022-01-19 | Pfizer-BioNTech | No |
| 4 | 2022-12-28 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release